Tanya Barauskas Dorff, M.D., is a medical oncologist and professor in the Department of Medical Oncology & Therapeutics Research. Full Bio. Dr. Tanya Dorff on New CAR T Cell Therapy for Prostate Cancer | ASCO22 Go to for more information on this important organization. Dr. Peter Zang, MD a second-year fellow at City of
A Day in the Life of Yuman Fong, M.D. | City of Hope Tanya B. Dorff, MD, Author at Grand Rounds in Urology
Findings from a Phase 1 Study of PSCA-targeted CAR T Cells in Patients with mCRPC | ASCO 2023 Meet Scientist Saul Priceman, Ph.D. | City of Hope
Tanya Dorff, M.D. on New Clinical Trial for Bladder Cancer | #ASCO21 Dr. Tanya Dorff discusses the clinical trial that is attempting to change the basic treatment paradigm for #bladdercancer patients
Dr. Tanya Dorff on Incorporating mCRPC Prognostic Models Into Clinical Practice Tanya Dorff, MD, elaborates on data investigating atezolizumab and cabozantinib in prostate cancer Tanya Dorff, MD, regarding the role of CAR-T cell therapy in the management of PSCA+ mCRPC
Keith David for NoShaver | City of Hope | :60 Attacking Prostate Cancer: The Latest Weapons | City of Hope Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD
Meet Larry Kwak, M.D., Ph.D. | City of Hope Stephen J. Forman, M.D., F.A.C.P., is the Francis and Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic
Dr. Tanya Dorff discusses how to prevent #bladdercancer and highlighted treatments currently available for patients. #ASCO21. Prostate Cancer Characteristics and Outcomes after Prostatectomy
Prostate Cancer Awareness - Newest Therapeutic Techniqu Dr. Tanya Barauskas Dorff is a medical oncologist in the Los Angeles area and an expert in GU cancers. Learn about her background and experience. Prostate Cancer Treatment Options City of Hope 001
Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's Hope Talks | The vision for City of Hope Orange County
Tanya Dorff, M.D., explains how CAR T therapy has the potential to benefit patients with prostate cancer and shares her prediction December "Researcher of the Month" Tanya Dorff, MD
Tanya Dorff, MD, City of Hope Comprehensive Cancer Center, explains the challenges of providing useful and accurate Two of City of Hope's most distinguished cancer experts — Ravi Salgia, M.D., Ph.D., and Sumanta Pal, M.D. — share more about
Dr. Tanya Barauskas Dorff, Medical Oncologist, Los Angeles Meet Hematologist Oncologist Bahareh Bahadini, M.D. | City of Hope Tanya Dorff, MD, on how checkpoint inhibitors are being incorporated into mCRPC treatment algorithms
City of Hope is special. I feel it really combines the science of medicine with the compassion of caring for individuals," says Purvi Hugo Godinez talks about NoShaver, a month-long journey during which participants stop shaving – to encourage men to get
Tanya Dorff, MD, on impressions of the CARD study investigating the role of cabazitaxel in mCRPC How City of Hope Saved My Life | A FabFitFun Team Member's Story | 2019 Fall Box Partner
Tanya B. Dorff, MD. City of Hope. Duarte, CA. Tanya B. Dorff, MD, serves as an Associate Clinical Professor in the Department of Medical Oncology Dr. Dorff, Medical Oncologist, Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, Head of
City of Hope is developing a comprehensive cancer campus and network of care in Orange County. Annette M. Walker, president MOASC Awards Peter Zang, MD $25,000 Grant 2025 Cary Presant, MD Young Investigator from City of Hope Navigating ADT Choices: Agonists Versus Antagonists and the Role of AR Pathway Inhibitors
Hematologist Leslie Popplewell, M.D, thinks that City of Hope patients feel the interaction and family atmosphere and that City of Hope doctor gets teen cancer patient tickets to World Series
What's the latest in prostate cancer research? Expert Dr. Tanya Dorff shares an overview of emerging prostate cancer therapies Tanya Dorff, MD, City of Hope Comprehensive Cancer Center.
John Park, M.D., Ph.D., is chief of the Division of Interventional Radiology at City of Hope. Learn more about Dr. Park at Tanya Dorff, MD, shares thoughts of the optimal sequence of atezolizumab and sip-T in mCRPC
Meet Our Doctors: Tanya Dorff, M.D. PSCA-CAR T cell therapy in metastatic castration-resistant prostate Dr. Tanya B. Dorff is an oncologist in Duarte, California and is affiliated with multiple hospitals in the area, including City of Hope Comprehensive Cancer
Tanya Dorff, a professor and medical oncologist at the City of Hope, where she runs clinical research and numerous trials in GU oncology and Keith David talks about NoShaver, a month-long journey during which participants stop shaving – to encourage men to get tested
ASCO 2019: Tanya Dorff, M.D. Advances in Prostate Cancer Imaging
Expert Dr. Tanya Dorff reviews the latest advances in prostate cancer imaging and explains the potential impact on patient care. Dr. Dorff, Associate Clinical Professor, City of Hope, shares on impressions of the CARD study presented at ASCO GU20 Bahareh Bahadini, M.D. serves as hematologist oncologist at City of Hope's Mission Hills location. She explains targeted therapy
In prostate cancer, the efficacy of CAR T cell therapies has been limited. Tanya Dorff, M.D., shares promising results from a Phase Meet John Park, M.D., Ph.D. | City of Hope
Hope Talks | Our doctors discuss the future of cancer care Meet Our Doctors: Stefanie Mooney, M.D. City of Hope participated in the first-ever #LAMedTechWeek, hosted by BioscienceLA, on March 21, 2021. During an engaging
Los Angeles-Area Prostate Cancer Care Team | City of Hope PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Tanya B. City of Hope conducted a single-center,
Vincent Chung, M.D., is a medical oncologist at City of Hope, and an expert on pancreatic cancer. Watch as he talks about how Dr. Dorff, Associate Clinical Professor, City of Hope, shares thoughts on the future of cellular immunotherapy versus checkpoint
Saul Priceman, Ph.D., is an assistant research professor at City of Hope. In this video, he explains the process by which he and Tanya Dorff, MD, on the future of cellular immunotherapy versus checkpoint inhibition in mPC Dr. Tanya Dorff, L.A.-Area Oncologist | City of Hope
Meet Our Doctors: Tanya Dorff, M.D. | City of Hope Dorff leads City of Hope's joint effort with the Prostate Cancer Foundation to develop novel immune-based strategies for prostate cancer. Specifically, she
MOASC Researcher of the Month Interview with Tanya Dorff, MD, City of Hope. Dr. Dorff discusses research in CAR-T Therapy in Prostate Cancer Program City of Hope Tanya Dorff, MD, explains the design and outcomes of the ACIS clinical trial
Dr. Dorff, Associate Clinical Professor, City of Hope, shares perspective on data presented at ASCO GU20 investigating Dr. Dorff, Associate Clinical Professor, City of Hope, shares thoughts of the optimal sequence of atezolizumab and sip-T in CAR T Therapy for Solid Tumors. Doctor Tanya Dorff Tanya Dorff, M.D.. The idea of training the body's own immune system to fight cancer has
Dr. Tanya Dorff, medical oncologist and section chief, Genitourinary Disease Program at City of Hope, a leading-edge cancer Meet Urologic Oncologist Bertram Yuh, M.D., M.S.H.C.P.M., M.I.S.M. | City of Hope Hope Talks | The Vision for Orange County
Tanya B. Dorff, MD, associate clinical professor, Department of Medical Oncology and Therapeutics Research, head, Our presence in Orange County is going to elevate cancer care, not just in the patients we treat in our facilities, but for all the
Meet Our Doctors: Purvi Patel, M.D. Spend a typical day with a pioneer both in the operating room and in the laboratory:Yuman Fong, M.D., the chair of City of Hope's
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Dr. Tanya Dorff, professor in Meet Our Doctors: Vincent Chung, M.D.
Dr. Dorff on Choosing Between Therapies in Nonmetastatic CRPC Hugo Godinez for NoShaver | OurHope | City of Hope
Have you joined the FabFitFun fam?: A cancer diagnosis is one of the scariest moments one can face. Tanya Dorff, M.D., is a medical oncologist specializing in genitourinary cancers at City of Hope. In this video, she speaks about
Hope Talks | Meet Ravi Salgia, M.D., Ph.D. Advancing Prostate Cancer Research and Leadership in Oncology
When 16-year-old Julian Palacios -- a lifelong Los Angeles Dodgers fan -- was preparing for a bone marrow transplant a few Dr. Tanya Dorff on The Future of CAR T Cell Therapy for Prostate Cancer | ASCO22
Does Prostate Cancer Hormone Therapy Cause Cognitive Issues? Tanya Dorff, M.D., associate clinical professor in the Department of Medical Oncology & Therapeutics Research at City of Hope,
I would encourage patients and physicians to think about earlier referral for clinical trials, in order to access the most exciting Meet Hematologist Leslie Popplewell, M.D. | City of Hope Tanya Dorff, M.D., shares details on a recent study which used CAR T cell therapy in patients with metastatic castration resistant
Dr. Tanya B. Dorff, MD | Duarte, CA | Oncologist | US News Doctors Tanya Dorff, M.D., on Bladder Cancer Treatments | #ASCO21 Dr. Tanya Dorff - Translating Discovery: Shaping Tomorrow's Prostate Cancer Therapies
An Expert Overview of Emerging Prostate Cancer Treatments At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, a roundtable of expert panelists convened Larry W. Kwak, M.D., Ph.D., is director of the Toni Stephenson Lymphoma Center and the Dr. Michael Friedman Professor in
Copy of Dr. Dorff on Choosing Between Therapies in Nonmetastatic CRPC Tanya Dorff, MD, on the role of chemotherapy in mCRPC patients who have failed prior therapies Dr. Yuh is a urological cancers surgical expert who joined City of Hope following the completion of a robotic surgery fellowship
Could hormone therapy for prostate cancer lead to cognitive issues? Expert Dr. Tanya Dorff discusses whether there's a link and Tanya Dorff, MD | GU Oncology Now Robotics in Cancer Surgery | City of Hope at #LAMedTechWeek
City of Hope has more than 1000 physicians and researchers singularly focused on cancer. It's a place where some of the most Epub 2021 Jul 10. Authors. Tanya Dorff , James Shen , Nora Ruel , Rick City of Hope Comprehensive Cancer Center, Department of medical Meet Stephen J. Forman, M.D., F.A.C.P. | City of Hope
The people who are in charge care a lot about the person as a whole," says Stefanie Mooney, M.D., a palliative-trained physician